Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Eradication Rates of Helicobacter Pylori With a New Sequential Treatment

NCT00132171 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT00132171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Eradication Rates of Helicobacter Pylori With a New Sequential Treatment
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2001
Completion date
December 31, 2001
Enrollment
1,000
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic active gastritis, duodenal ulcer, gastric ulcer, gastritis, helicobacter pylori infection, non ulcer dyspepsia